H2S Inhibits Hyperglycemia-Induced Intrarenal Renin-Angiotensin System Activation via Attenuation of Reactive Oxygen Species Generation

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Xue, Hong ^a   Yuan, Ping ^a,b   Ni, Jun ^a   Li, Chen ^b   Shao, Decui ^a   Liu, Jia ^a   Shen, Yang ^a   Wang, Zhen ^a   Zhou, Li ^a   Zhang, Wei ^a   Huang, Yu ^c   Yu, Chen ^b   Wang, Rui ^a,d   Lu, Limin ^a  

^a FUDAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d LAKEHEAD UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; BROXURIDINE; COLLAGEN TYPE 4; CYSTATHIONINE GAMMA LYASE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPHENYLENECHLORIDE IODONIUM; FLUORESCENT DYE; GLUCOSE; HYDROGEN SULFIDE; MESSENGER RNA; OXIDOREDUCTASE INHIBITOR; PROPARGYLGLYCINE; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DRUG MECHANISM; ENZYME IMMUNOASSAY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; MESANGIUM CELL; MITOSIS RATE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ACETOPHENONES; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSINOGEN; ANIMALS; BLOOD GLUCOSE; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE IV; CYSTATHIONINE BETA-SYNTHASE; CYSTATHIONINE GAMMA-LYASE; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; HYDROGEN SULFIDE; HYPERGLYCEMIA; KIDNEY; LOSARTAN; MESANGIAL CELLS; NADPH OXIDASE; ONIUM COMPOUNDS; PEPTIDYL-DIPEPTIDASE A; RATS; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84884160965     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074366     Document Type: Article

References (45)

1. Ritz E, Rychlík I, Locatelli F, Halimi S, (1999) End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis 34: 795-808. doi:10.1016/S0272-6386(99)70035-1. PubMed: 10561134.
2. Davis LK, Rodgers BD, Kelley KM, (2008) Angiotensin II- and glucose-stimulated extracellular matrix production: mediation by the insulin-like growth factor (IGF) axis in a murine mesangial cell line. Endocrine 33: 32-39. doi:10.1007/s12020-008-9055-0. PubMed: 18392786.
3. Steffes MW, Osterby R, Chavers B, Mauer SM, (1989) Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38: 1077-1081. doi:10.2337/diabetes.38.9.1077. PubMed: 2670639.
4. Szabo C, (2012) Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 17: 68-80. doi:10.1089/ars.2011.4451. PubMed: 22149162.
5. Yang G, Wu L, Bryan S, Khaper N, Mani S, et al. (2010) Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells. Cardiovasc Res 86: 487-495. doi:10.1093/cvr/cvp420. PubMed: 20051385.
6. Zuidema MY, Peyton KJ, Fay WP, Durante W, Korthuis RJ, (2011) Antecedent hydrogen sulfide elicits an anti-inflammatory phenotype in postischemic murine small intestine: role of heme oxygenase-1. Am J Physiol Heart Circ Physiol 301: H888-H894. doi:10.1152/ajpheart.00432.2010. PubMed: 21666111.
7. Łowicka E, Bełtowski J, (2007) Hydrogen sulfide (H2S)- the third gas of interest for pharmacologists. Pharmacol Rep 59: 4-24. PubMed: 17377202.
8. Wang R, (2012) Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev 92: 791-896. doi:10.1152/physrev.00017.2011. PubMed: 22535897.
9. Xia M, Chen L, Muh RW, Li PL, Li N, (2009) Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys. J Pharmacol Exp Ther 329: 1056-1062. doi:10.1124/jpet.108.149963. PubMed: 19246614.
10. Aminzadeh MA, Vaziri ND, (2012) Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease. Nephrol Dial Transplant 27: 498-504. doi:10.1093/ndt/gfr560. PubMed: 22036943.
11. Tripatara P, Patel NS, Collino M, Gallicchio M, Kieswich J, et al. (2008) Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest 88: 1038-1048. doi:10.1038/labinvest.2008.73. PubMed: 18679378.
12. Yuan P, Xue H, Zhou L, Qu L, Li C, et al. (2011) Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide. Nephrol Dial Transplant 26: 2119-2126. doi:10.1093/ndt/gfq749. PubMed: 21208996.
13. Ahmad FU, Sattar MA, Rathore HA, Abdullah MH, Tan S, et al. (2012) Exogenous hydrogen sulfide (H2S) reduces blood pressure and prevents the progression of diabetic nephropathy in spontaneously hypertensive rats. Ren Fail 34: 203-210. PubMed: 22229751.
14. Yamamoto J, Sato W, Kosugi T, Yamamoto T, Kimura T, et al. (2013) Distribution of hydrogen sulfide (H(2) S)-producing enzymes and the roles of the H(2)S donor sodium hydrosulfide in diabetic nephropathy. Clin Exp Nephrol 17: 32-40. doi:10.1007/s10157-012-0670-y. PubMed: 22872231.
15. Sen U, Sathnur PB, Kundu S, Givvimani S, Coley DM, et al. (2012) Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia. Am J Physiol Cell Physiol 303: C41-C51. doi:10.1152/ajpcell.00398.2011. PubMed: 22517358.
16. Bracht H, Scheuerle A, Gröger M, Hauser B, Matallo J, et al. (2012) Effects of intravenous sulfide during resuscitated porcine hemorrhagic shock*. Crit Care Med 40: 2157-2167. doi:10.1097/CCM.0b013e31824e6b30. PubMed: 22713217.
17. Francescato HD, Chierice JR, Marin EC, Cunha FQ, Costa RS, et al. (2012) Effect of endogenous hydrogen sulfide inhibition on structural and functional renal disturbances induced by gentamicin. Braz J Med Biol Res 45: 244-249. doi:10.1590/S0100-879X2012007500016. PubMed: 22331137.
18. Brewster UC, Perazella MA, (2004) The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med 116: 263-272. doi:10.1016/j.amjmed.2003.09.034. PubMed: 14969655.
19. Kobori H, Nangaku M, Navar LG, Nishiyama A, (2007) The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251-287. doi:10.1124/pr.59.3.3. PubMed: 17878513.
20. Jaimes EA, Hua P, Tian RX, Raij L, (2010) Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress. Am J Physiol Renal Physiol 298: F125-F132. doi:10.1152/ajprenal.00248.2009. PubMed: 19864304.
21. Luft FC, (2010) New insights into angiotensin, reactive oxygen and endothelial function. Nephrol Dial Transplant 25: 2099-2101. doi:10.1093/ndt/gfq201. PubMed: 20576726.
22. Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, et al. (2009) Activation of reactive oxygen species and the renin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol 36: 509-515. doi:10.1111/j.1440-1681.2008.05107.x. PubMed: 19673933.
23. Lu M, Liu YH, Goh HS, Wang JJ, Yong QC, et al. (2010) Hydrogen sulfide inhibits plasma renin activity. J Am Soc Nephrol 21: 993-1002. doi:10.1681/ASN.2009090949. PubMed: 20360313.
24. Lan A, Liao X, Mo L, Yang C, Yang Z, et al. (2011) Hydrogen sulfide protects against chemical hypoxia-induced injury by inhibiting ROS-activated ERK1/2 and p38MAPK signaling pathways in PC12 cells. PLOS ONE 6: e25921. doi:10.1371/journal.pone.0025921. PubMed: 21998720.
25. Mishra PK, Tyagi N, Sen U, Givvimani S, Tyagi SC, (2010) H2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure. Am J Physiol Heart Circ Physiol 298: H451-H456. doi:10.1152/ajpheart.00682.2009. PubMed: 19933416.
26. Strege PR, Bernard CE, Kraichely RE, Mazzone A, Sha L, et al. (2011) Hydrogen sulfide is a partially redox-independent activator of the human jejunum Na+ channel, Nav1.5. Am J Physiol Gastrointest Liver Physiol 300: G1105-G1114. doi:10.1152/ajpgi.00556.2010. PubMed: 21393430.
27. Zhou L, Xue H, Yuan P, Ni J, Yu C, et al. (2010) Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells. Clin Exp Pharmacol Physiol 37: e152-e157. doi:10.1111/j.1440-1681.2010.05421.x. PubMed: 20590668.
28. Ding G, Reddy K, Kapasi AA, Franki N, Gibbons N, et al. (2002) Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 283: F173-F180. PubMed: 12060599.
29. Pavenstädt H, Kriz W, Kretzler M, (2003) Cell biology of the glomerular podocyte. Physiol Rev 83: 253-307. PubMed: 12506131.
30. Wennmann DO, Hsu HH, Pavenstädt H, (2012) The renin-angiotensin-aldosterone system in podocytes. Semin Nephrol 32: 377-384. doi:10.1016/j.semnephrol.2012.06.009. PubMed: 22958492.
31. Ohashi N, Urushihara M, Satou R, Kobori H, (2010) Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species--ERK/JNK pathways. Hypertens Res 33: 1174-1181. doi:10.1038/hr.2010.143. PubMed: 20686488.
32. Amiri F, Shaw S, Wang X, Tang J, Waller JL, et al. (2002) Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int 61: 1605-1616. doi:10.1046/j.1523-1755.2002.00311.x. PubMed: 11967010.
33. Asbun J, Manso AM, Villarreal FJ, (2005) Profibrotic influence of high glucose concentration on cardiac fibroblast functions: effects of losartan and vitamin E. Am J Physiol Heart Circ Physiol 288: H227-H234. PubMed: 15345478.
34. Catherwood MA, Powell LA, Anderson P, McMaster D, Sharpe PC, et al. (2002) Glucose-induced oxidative stress in mesangial cells. Kidney Int 61: 599-608. doi:10.1046/j.1523-1755.2002.00168.x. PubMed: 11849402.
35. de Cavanagh EM, Ferder LF, Ferder MD, Stella IY, Toblli JE, et al. (2010) Vascular structure and oxidative stress in salt-loaded spontaneously hypertensive rats: effects of losartan and atenolol. Am J Hypertens 23: 1318-1325. doi:10.1038/ajh.2010.167. PubMed: 20706197.
36. Chrissobolis S, Banfi B, Sobey CG, Faraci FM, (2012) Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain. J Appl Physiol 113: 184-191. doi:10.1152/japplphysiol.00455.2012. PubMed: 22628375.
37. Fortuño A, Bidegain J, Robador PA, Hermida J, López-Sagaseta J, et al. (2009) Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension. Hypertension 54: 744-750. doi:10.1161/HYPERTENSIONAHA.109.129353. PubMed: 19687351.
38. Fujita K, Yamafuji M, Nakabeppu Y, Noda M, (2012) Therapeutic approach to neurodegenerative diseases by medical gases: focusing on redox signaling and related antioxidant enzymes. Oxid Med Cell Longev(2012): pp. 324256.
39. Muzaffar S, Shukla N, Bond M, Newby AC, Angelini GD, et al. (2008) Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. J Vasc Res 45: 521-528. doi:10.1159/000129686. PubMed: 18463417.
40. Zhong X, Wang L, Wang Y, Dong S, Leng X, et al. (2012) Exogenous hydrogen sulfide attenuates diabetic myocardial injury through cardiac mitochondrial protection. Mol Cell Biochem 371: 187-198. doi:10.1007/s11010-012-1435-3. PubMed: 23001844.
41. Suzuki K, Olah G, Modis K, Coletta C, Kulp G, et al. (2011) Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci U S A 108: 13829-13834. doi:10.1073/pnas.1105121108. PubMed: 21808008.
42. Si YF, Wang J, Guan J, Zhou L, Sheng Y, et al. (2013) Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats. Br J Pharmacol 169: 619-631. doi:10.1111/bph.12163. PubMed: 23488985.
43. Monosíková J, Zeman M, Veselá A, Herichová I, (2009) Down regulation of angiotensin II receptor AT1 expression in the pancreas of diabetic rat. Exp Clin Endocrinol Diabetes 117: 438-439. doi:10.1055/s-0029-1216376. PubMed: 19472100.
44. Shao Y, He M, Zhou L, Yao T, Huang Y, et al. (2008) Chronic angiotensin (1-7) injection accelerates STZ-induced diabetic renal injury. Acta Pharmacol Sin 29: 829-837. doi:10.1111/j.1745-7254.2008.00812.x. PubMed: 18565281.
45. Yano N, Suzuki D, Endoh M, Cao TN, Dahdah JR, et al. (2009) High ambient glucose induces angiotensin-independent AT-1 receptor activation, leading to increases in proliferation and extracellular matrix accumulation in MES-13 mesangial cells. Biochem J 423: 129-143. doi:10.1042/BJ20082277. PubMed: 19604148.